| 2021年 12月31日 | 2022年 12月31日 | 2023年 12月31日 |
---|
Net income (loss) | -407 | -107 | -263 |
---|
Depreciation and amortization | 15 | 14 | 20 |
---|
Stock-based compensation expense | 292 | 28 | 69 |
---|
Depreciation and amortization | 15 | 14 | 20 |
---|
Loss on debt extinguishment | -2 | - | - |
---|
Stock-based compensation expense | 292 | 28 | 69 |
---|
Loss (income) from equity method investments | -7 | 11 | 16 |
---|
Loss on debt extinguishment | -2 | - | - |
---|
Deferred income taxes and uncertain tax positions | 3 | -1 | - |
---|
Loss (income) from equity method investments | -7 | 11 | 16 |
---|
Release of indemnification assets | -2 | -1 | - |
---|
Deferred income taxes and uncertain tax positions | 3 | -1 | - |
---|
(Gain) loss on sale of assets, net | 0 | - | -48 |
---|
Release of indemnification assets | -2 | -1 | - |
---|
Distributions of earnings from equity method investments | -0 | - | - |
---|
(Gain) loss on sale of assets, net | 0 | - | -48 |
---|
Other non-cash items | -0 | -3 | 4 |
---|
Distributions of earnings from equity method investments | -0 | - | - |
---|
Other non-cash items | -0 | -3 | 4 |
---|
Net income (loss) | -407 | -107 | -263 |
---|
Receivables, net | 149 | 204 | 460 |
---|
Prepaid expense and other current assets | 4 | 17 | 6 |
---|
Receivables, net | 149 | 204 | 460 |
---|
Other assets | -4 | 0 | 0 |
---|
Prepaid expense and other current assets | 4 | 17 | 6 |
---|
Medical claims and related payables | -76 | -108 | -441 |
---|
Other assets | -4 | 0 | 0 |
---|
Accounts payable and accrued expenses | 19 | 66 | 32 |
---|
Medical claims and related payables | -76 | -108 | -441 |
---|
Other liabilities | -2 | -12 | -17 |
---|
Accounts payable and accrued expenses | 19 | 66 | 32 |
---|
Other liabilities | -2 | -12 | -17 |
---|
Depreciation and amortization | 15 | 14 | 20 |
---|
Stock-based compensation expense | 292 | 28 | 69 |
---|
Depreciation and amortization | 15 | 14 | 20 |
---|
Loss on debt extinguishment | -2 | - | - |
---|
Stock-based compensation expense | 292 | 28 | 69 |
---|
Loss (income) from equity method investments | -7 | 11 | 16 |
---|
Loss on debt extinguishment | -2 | - | - |
---|
Deferred income taxes and uncertain tax positions | 3 | -1 | - |
---|
Loss (income) from equity method investments | -7 | 11 | 16 |
---|
Release of indemnification assets | -2 | -1 | - |
---|
Deferred income taxes and uncertain tax positions | 3 | -1 | - |
---|
(Gain) loss on sale of assets, net | 0 | - | -48 |
---|
Release of indemnification assets | -2 | -1 | - |
---|
Distributions of earnings from equity method investments | -0 | - | - |
---|
(Gain) loss on sale of assets, net | 0 | - | -48 |
---|
Other non-cash items | -0 | -3 | 4 |
---|
Distributions of earnings from equity method investments | -0 | - | - |
---|
Other non-cash items | -0 | -3 | 4 |
---|
Net cash provided by (used in) operating activities | -148 | -131 | -156 |
---|
Receivables, net | 149 | 204 | 460 |
---|
Prepaid expense and other current assets | 4 | 17 | 6 |
---|
Receivables, net | 149 | 204 | 460 |
---|
Other assets | -4 | 0 | 0 |
---|
Prepaid expense and other current assets | 4 | 17 | 6 |
---|
Medical claims and related payables | -76 | -108 | -441 |
---|
Other assets | -4 | 0 | 0 |
---|
Accounts payable and accrued expenses | 19 | 66 | 32 |
---|
Medical claims and related payables | -76 | -108 | -441 |
---|
Other liabilities | -2 | -12 | -17 |
---|
Accounts payable and accrued expenses | 19 | 66 | 32 |
---|
Other liabilities | -2 | -12 | -17 |
---|
Net cash provided by (used in) operating activities | -148 | -131 | -156 |
---|
Purchase of property and equipment | 7 | 15 | 16 |
---|
Purchase of intangible assets | 7 | 17 | 15 |
---|
Purchase of property and equipment | 7 | 15 | 16 |
---|
Investments in loans receivable and other | 83 | 7 | 20 |
---|
Purchase of intangible assets | 7 | 17 | 15 |
---|
Investments in marketable securities | - | 458 | 115 |
---|
Investments in loans receivable and other | 83 | 7 | 20 |
---|
Proceeds from Sale and Maturity of Marketable Securities | - | 53 | - |
---|
Investments in marketable securities | - | 458 | 115 |
---|
Proceeds from Divestiture of Businesses, Net of Cash Divested | -1 | 1 | 2 |
---|
Proceeds from maturities and sales of marketable securities and other | - | - | 164 |
---|
Net cash provided by (used in) investing activities | -91 | -444 | -44 |
---|
Net cash paid in business combination | - | - | 45 |
---|
Proceeds from Divestiture of Businesses, Net of Cash Divested | -1 | 1 | 2 |
---|
Net cash provided by (used in) investing activities | -91 | -444 | -44 |
---|
Net income (loss) | -407 | -107 | -263 |
---|
Depreciation and amortization | 15 | 14 | 20 |
---|
Stock-based compensation expense | 292 | 28 | 69 |
---|
Depreciation and amortization | 15 | 14 | 20 |
---|
Loss on debt extinguishment | -2 | - | - |
---|
Stock-based compensation expense | 292 | 28 | 69 |
---|
Loss (income) from equity method investments | -7 | 11 | 16 |
---|
Loss on debt extinguishment | -2 | - | - |
---|
Deferred income taxes and uncertain tax positions | 3 | -1 | - |
---|
Loss (income) from equity method investments | -7 | 11 | 16 |
---|
Release of indemnification assets | -2 | -1 | - |
---|
Deferred income taxes and uncertain tax positions | 3 | -1 | - |
---|
(Gain) loss on sale of assets, net | 0 | - | -48 |
---|
Release of indemnification assets | -2 | -1 | - |
---|
Distributions of earnings from equity method investments | -0 | - | - |
---|
(Gain) loss on sale of assets, net | 0 | - | -48 |
---|
Other non-cash items | -0 | -3 | 4 |
---|
Distributions of earnings from equity method investments | -0 | - | - |
---|
Other non-cash items | -0 | -3 | 4 |
---|
Net income (loss) | -407 | -107 | -263 |
---|
Receivables, net | 149 | 204 | 460 |
---|
Prepaid expense and other current assets | 4 | 17 | 6 |
---|
Receivables, net | 149 | 204 | 460 |
---|
Other assets | -4 | 0 | 0 |
---|
Prepaid expense and other current assets | 4 | 17 | 6 |
---|
Medical claims and related payables | -76 | -108 | -441 |
---|
Other assets | -4 | 0 | 0 |
---|
Accounts payable and accrued expenses | 19 | 66 | 32 |
---|
Medical claims and related payables | -76 | -108 | -441 |
---|
Other liabilities | -2 | -12 | -17 |
---|
Accounts payable and accrued expenses | 19 | 66 | 32 |
---|
Other liabilities | -2 | -12 | -17 |
---|
Depreciation and amortization | 15 | 14 | 20 |
---|
Stock-based compensation expense | 292 | 28 | 69 |
---|
Depreciation and amortization | 15 | 14 | 20 |
---|
Loss on debt extinguishment | -2 | - | - |
---|
Stock-based compensation expense | 292 | 28 | 69 |
---|
Loss (income) from equity method investments | -7 | 11 | 16 |
---|
Loss on debt extinguishment | -2 | - | - |
---|
Deferred income taxes and uncertain tax positions | 3 | -1 | - |
---|
Loss (income) from equity method investments | -7 | 11 | 16 |
---|
Release of indemnification assets | -2 | -1 | - |
---|
Deferred income taxes and uncertain tax positions | 3 | -1 | - |
---|
(Gain) loss on sale of assets, net | 0 | - | -48 |
---|
Release of indemnification assets | -2 | -1 | - |
---|
Distributions of earnings from equity method investments | -0 | - | - |
---|
(Gain) loss on sale of assets, net | 0 | - | -48 |
---|
Other non-cash items | -0 | -3 | 4 |
---|
Distributions of earnings from equity method investments | -0 | - | - |
---|
Other non-cash items | -0 | -3 | 4 |
---|
Net cash provided by (used in) operating activities | -148 | -131 | -156 |
---|
Receivables, net | 149 | 204 | 460 |
---|
Prepaid expense and other current assets | 4 | 17 | 6 |
---|
Receivables, net | 149 | 204 | 460 |
---|
Other assets | -4 | 0 | 0 |
---|
Prepaid expense and other current assets | 4 | 17 | 6 |
---|
Medical claims and related payables | -76 | -108 | -441 |
---|
Other assets | -4 | 0 | 0 |
---|
Accounts payable and accrued expenses | 19 | 66 | 32 |
---|
Medical claims and related payables | -76 | -108 | -441 |
---|
Other liabilities | -2 | -12 | -17 |
---|
Accounts payable and accrued expenses | 19 | 66 | 32 |
---|
Other liabilities | -2 | -12 | -17 |
---|
Net cash provided by (used in) operating activities | -148 | -131 | -156 |
---|
Proceeds from initial public offering | 1,171 | - | - |
---|
Proceeds from Issuance of Common Stock | - | 33 | 12 |
---|
Proceeds from initial public offering | 1,171 | - | - |
---|
Common stock repurchase | - | - | 200 |
---|
Proceeds from Issuance of Common Stock | - | 33 | 12 |
---|
Proceeds from Issuance of Long-Term Debt | 100 | - | - |
---|
Common stock repurchase | - | - | 200 |
---|
Repayments of long-term borrowings and other | 120 | 5 | 5 |
---|
Proceeds from Issuance of Long-Term Debt | 100 | - | - |
---|
Equity and debt issuance costs and other | 15 | - | - |
---|
Repayments of long-term borrowings and other | 120 | 5 | 5 |
---|
Equity and debt issuance costs and other | 15 | - | - |
---|
Net cash provided by (used in) financing activities | 1,154 | 28 | -193 |
---|
Purchase of property and equipment | 7 | 15 | 16 |
---|
Purchase of intangible assets | 7 | 17 | 15 |
---|
Purchase of property and equipment | 7 | 15 | 16 |
---|
Investments in loans receivable and other | 83 | 7 | 20 |
---|
Purchase of intangible assets | 7 | 17 | 15 |
---|
Investments in marketable securities | - | 458 | 115 |
---|
Investments in loans receivable and other | 83 | 7 | 20 |
---|
Proceeds from Sale and Maturity of Marketable Securities | - | 53 | - |
---|
Investments in marketable securities | - | 458 | 115 |
---|
Proceeds from Divestiture of Businesses, Net of Cash Divested | -1 | 1 | 2 |
---|
Proceeds from maturities and sales of marketable securities and other | - | - | 164 |
---|
Net cash provided by (used in) investing activities | -91 | -444 | -44 |
---|
Net cash paid in business combination | - | - | 45 |
---|
Proceeds from Divestiture of Businesses, Net of Cash Divested | -1 | 1 | 2 |
---|
Net cash provided by (used in) investing activities | -91 | -444 | -44 |
---|
Net increase (decrease) in cash, cash equivalents and restricted cash and equivalents | 916 | -547 | -393 |
---|
Proceeds from initial public offering | 1,171 | - | - |
---|
Proceeds from Issuance of Common Stock | - | 33 | 12 |
---|
Proceeds from initial public offering | 1,171 | - | - |
---|
Common stock repurchase | - | - | 200 |
---|
Proceeds from Issuance of Common Stock | - | 33 | 12 |
---|
Proceeds from Issuance of Long-Term Debt | 100 | - | - |
---|
Common stock repurchase | - | - | 200 |
---|
Repayments of long-term borrowings and other | 120 | 5 | 5 |
---|
Proceeds from Issuance of Long-Term Debt | 100 | - | - |
---|
Equity and debt issuance costs and other | 15 | - | - |
---|
Repayments of long-term borrowings and other | 120 | 5 | 5 |
---|
Equity and debt issuance costs and other | 15 | - | - |
---|
Net cash provided by (used in) financing activities | 1,154 | 28 | -193 |
---|
Net increase (decrease) in cash, cash equivalents and restricted cash and equivalents | 916 | -547 | -393 |
---|